These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15991613)

  • 1. [Atrial fibrillation and anticoagulant therapy].
    Mokaddem A; Khouadja MA; Dargouth B; Sdiri W; Joulak A; Saidi I; Selmi K; Makni H; Boujnah MR
    Tunis Med; 2005 Feb; 83 Suppl 2():1-5. PubMed ID: 15991613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 4. A promising advance in anticoagulant therapy for patients with atrial fibrillation.
    Olsson SB
    Ital Heart J; 2004 May; 5(5):335-9. PubMed ID: 15185895
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation.
    Weintraub WS
    J Am Coll Cardiol; 2008 Feb; 51(8):816-7. PubMed ID: 18294565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulant therapy in patients with atrial fibrillation on dialysis: between the risk of hemorrhage and vascular calcification].
    Cozzolino M; Ronga C; Cusi D
    G Ital Nefrol; 2010; 27(3):237-9. PubMed ID: 20540016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Age and anticoagulant therapy].
    Halinen MO
    Duodecim; 2001; 117(16):1656-62. PubMed ID: 12182105
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 14. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Hoefnagels WA; van Reisen AG
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):267-8; author reply 268-9. PubMed ID: 12621983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulants in non-rheumatic atrial fibrillation].
    van Gennip A; Hellemons-Boode B; Krebber T; Langenberg-Ledeboer M
    Ned Tijdschr Geneeskd; 1992 Jan; 136(4):195-6. PubMed ID: 1736135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atrial fibrillation in dialysis patients].
    Vázquez Ruiz de Castroviejo E; Sánchez Perales MC
    Nefrologia; 2006; 26(1):16-24. PubMed ID: 16649422
    [No Abstract]   [Full Text] [Related]  

  • 20. Choice of an oral anticoagulant in atrial fibrillation.
    Med Lett Drugs Ther; 2012 Oct; 54(1400):79-80. PubMed ID: 23018987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.